Experimental studies have shown that suppressing miR-155 expression in DKD mice protects against kidney damage, attenuates hyperglycaemia-induced kidney damage and downregulates IL-17 expression by enhancing the suppression of cytokine signalling 1 (SOCS1) [114]. The gene discussed is SOCS1; the disease is Hyperglycemia.